Efficacy and Safety of CNV2197944 Versus Placebo in Patients With Post-herpetic Neuralgia

Summary

To investigate the effect of repeat oral dosing of CNV2197944 75 mg tid on the pain experienced in post-herpetic neuralgia (PHN) as measured by changes in PI-NRS after three weeks of treatment compared to the baseline period.

Timeline

Start

2013-04

Primary completion

2014-02

Completion

2014-05

Drugs

Indications